Blockade of Common Gamma Chain Cytokine Signaling With REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody
Time: 2:40 pm
day: Conference Day One
Details:
- Blockade of cytokine signalling protected mice against immune cell-mediated pathology in multiple disease models
- Providing evidence of γc cytokines as key drivers of pathogenic immune cell responses
- Offering a potentially novel strategy for the management of inflammatory and autoimmune diseases, such as GVHD, immune aplastic anemia and MS
